Keywords: adventrx, grants, shin, poong, rights, anx-514, south

Adventrx grants Shin Poong rights to ANX-514 in South Korea

Article | 30 March 2009

Print This

The USA's Adventrx Pharmaceuticals has granted Shin Poong Pharmaceutical exclusive rights in South Korea to make, use and sell ANX-514 ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in